Smith & Nephew unveiled a new hospital-focused sales model that will offer two of the company’s primary hip and knee implants through multiyear contracts at an approximate discounted rate of one-third.
The new system is called Syncera, and Smith & Nephew anticipates the two products offered under it, Genesis II Knee, and the combination of the Synergy hip stem and reflection cap, are suitable for roughly 80% of all hip and knee procedures undertaken in the United States.
Along with reconstructive implants, the delivery program will also provide basic technical support in the operating room and supplemental technology to help streamline customer’s supply chain and logistics. Management believes this type of model can lead to more attractive economics for patients, payers and providers as it offers automatic ordering and product replenishment, point-of-care automated tools, comprehensive pre-launch training and support, and access to technical and live account support when needed. Syncera is projected to generate overall cost savings of 40-50% for participating customers.
